Homepage
A Statement from our Co-Founders and Co-CEOs Glen de Vries and Tarek Sherif
Your Research Brings Hope To Millions of Patients. Our Platform Accelerates it.
Acorn AI is designed to make data liquid across the lifecycle and answer the most important questions.
The Impact of COVID-19 on Clinical Trial Sites
Medidata surveyed over 1,000 sites to see how the COVID-19 pandemic is affecting their ability to start, conduct and complete clinical studies.
COVID-19 and Clinical Trials: The Medidata Perspective
Release 7.0
As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.
[SCOPE Webinar] How Five COVID-19 Technology Innovations are Reducing Risk in Clinical Trials
Join our next panel discussion—including live Q&A—exploring how regulators and sponsors have reimagined technology innovations addressing the impact of COVID-19.
Stay ahead of life sciences' challenges with the latest in the news and on social media.
Help Us Power Technology That Changes Lives